Wealthfront Advisers’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$686K Sell
3,259
-2,908
-47% -$623K ﹤0.01% 802
2026
Q1
$1.36M Sell
6,167
-195
-3% -$47.7K ﹤0.01% 665
2025
Q4
$1.61M Buy
6,362
+782
+14% +$196K ﹤0.01% 626
2025
Q3
$1.38M Buy
5,580
+828
+17% +$198K ﹤0.01% 643
2025
Q2
$1.14M Buy
4,752
+1,869
+65% +$435K ﹤0.01% 658
2025
Q1
$653K Buy
2,883
+1,004
+53% +$221K ﹤0.01% 737
2024
Q4
$386K Sell
1,879
-339
-15% -$74.4K ﹤0.01% 807
2024
Q3
$538K Buy
2,218
+54
+2% +$12.6K ﹤0.01% 755
2024
Q2
$475K Sell
2,164
-50
-2% -$10.9K ﹤0.01% 746
2024
Q1
$498K Buy
2,214
+381
+21% +$85.9K ﹤0.01% 731
2023
Q4
$403K Sell
1,833
-1,774
-49% -$375K ﹤0.01% 751
2023
Q3
$791K Buy
3,607
+1,735
+93% +$392K ﹤0.01% 602
2023
Q2
$421K Sell
1,872
-60
-3% -$12K ﹤0.01% 716
2023
Q1
$370K Buy
1,932
+196
+11% +$37.9K ﹤0.01% 719
2022
Q4
$321K Sell
1,736
-240
-12% -$42.2K ﹤0.01% 708
2022
Q3
$329K Sell
1,976
-742
-27% -$151K ﹤0.01% 676
2022
Q2
$560K Sell
2,718
-948
-26% -$214K ﹤0.01% 572
2022
Q1
$886K Sell
3,666
-198
-5% -$45.9K ﹤0.01% 538
2021
Q4
$940K Buy
3,864
+894
+30% +$204K ﹤0.01% 501
2021
Q3
$607K Buy
2,970
+628
+27% +$134K ﹤0.01% 535
2021
Q2
$483K Buy
2,342
+335
+17% +$67.4K ﹤0.01% 525
2021
Q1
$382K Buy
2,007
+183
+10% +$34K ﹤0.01% 484
2020
Q4
$346K Buy
1,824
+116
+7% +$21.6K ﹤0.01% 479
2020
Q3
$301K Buy
1,708
+263
+18% +$42.1K ﹤0.01% 464
2020
Q2
$222K Sell
1,445
-22
-1% -$3.35K ﹤0.01% 490
2020
Q1
$205K Sell
1,467
-10
-0.7% -$1.5K ﹤0.01% 428
2019
Q4
$225K Buy
1,477
+71
+5% +$10.4K ﹤0.01% 479
2019
Q3
$203K Sell
1,406
-11
-0.8% -$1.64K ﹤0.01% 467
2019
Q2
$211K Buy
+1,417
New +$189K ﹤0.01% 477

Other funds holding STE

Wealthfront Advisers's STE Position: Q2 2026 in Review

Wealthfront Advisers reduced its Steris (STE) stake by 47% in Q2 2026, selling an estimated $623K and leaving 3,259 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #802.

Wealthfront Advisers first reported a position in STE in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.61M in Q4 2025. 591 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Wealthfront Advisers held 3,259 shares of Steris worth $686K as of Q2 2026.
  • Wealthfront Advisers sold 2,908 Steris shares in Q2 2026, an estimated $623K.
  • Steris made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #802 holding.
  • Wealthfront Advisers first reported a position in Steris in Q2 2019 and has held it in 29 quarters since.
  • Wealthfront Advisers's Steris position peaked at $1.61M in Q4 2025.
  • 591 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.